Palantir bear Morgan Stanley upgrades rating but still doesn’t call AI firm a buy

• These are the companies that can withstand extreme tariff strain, says Morgan Stanley’s Mike Wilson

  Investors looking for havens from tariff strain should lean toward goods-oriented companies with stronger pricing power, says Morgan Stanley’s Mike Wilson.
  
  MarketWatch - 21h

• Morgan Stanley CEO Ted Pick says bank will work with U.S. regulators on offering crypto

  Morgan Stanley, a juggernaut in the wealth management industry, has been repeatedly ahead of its peers when it comes to crypto.
  
  CNBC - Jan. 23

• Morgan Stanley more bullish on M&A as equity and bond revenues climb

  Morgan Stanley beats earnings expectations amid strength in its equity and bond businesses.
  
  MarketWatch - Jan. 16

• Morgan Stanley tops estimates on strong equities and fixed income trading revenue

  The bank's massive wealth management business will be helped by high stock market values in the fourth quarter, which inflates the management fees it collects.
  
  CNBC - Jan. 16

• Morgan Stanley earnings jump on soaring trading and dealmaking revenues

  Rival Goldman Sachs similarly reported robust performance in markets and investment banking units
  
  Financial Times - Jan. 16

• These are the stocks that Morgan Stanley’s Mike Wilson sees standing up to rising rates

  Investors should stick to quality names amid rising rates, says a team led by Morgan Stanley’s Mike Wilson.
  
  MarketWatch - Jan. 13
• 

  Bottom Line: Palantir taps Trump-tied firm as it chases government contracts

  Defense ​Palantir Technologies has hired Miller Strategies to lobby on issues related to defense policy and appropriations. The U.S. government has awarded Palantir nearly $2.5 billion in contracts ...
  
  The Hill - Jan. 8

• Palantir has this rare distinction as Morgan Stanley says stock price is too high

  Morgan Stanley assigned a new analyst to cover hot artificial intelligence stock Palantir Technologies, and the Wall Street firm joined the ranks forecasting worse times ahead for the stock.
  
  MarketWatch - Jan. 7

• Dumping losers to buy Tesla or Palantir seems like a no-brainer. It isn't.

  We have two stocks that are worth owning, but only on ethos not on earnings.
  
  CNBC - Jan. 5

More from MarketWatch

• Spotify swings to a profit as subscribers top estimates

  The streaming service reported a double-digit rise in monthly active users.
  
  MarketWatch - 11m

• Spotify swings to a profit as subscribers top estimates

  The streaming service reported a double-digit rise in monthly active users.
  
  MarketWatch - 11m

• The tariff wars aren’t over. China hits back over new 10% tariffs.

  U.S. agreements with Canada and Mexico stopped tariffs before they were to enter into effect, but the trade war between the world’s top two economies is continuing.
  
  MarketWatch - 14m

• Merck’s soft guidance overshadows quarterly beat to send stock down 6%

  Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.
  
  MarketWatch - 19m

• Trump has two strong options to defuse the U.S. debt time-bomb. He should use them.

  AI-fueled productivity growth, combined with realistic and constructive immigration reform, would put the U.S. economy on more solid footing.
  
  MarketWatch - 31m

More in Business

• Luxury carmaker Ferrari posts 21% hike in full-year profit, sees 2025 growth

  Luxury carmaker Ferrari on Tuesday reported a significant upswing in full-year net profit, citing a strong product mix and growing demand for personalization.
  
  CNBC - 8m

• Spotify swings to a profit as subscribers top estimates

  The streaming service reported a double-digit rise in monthly active users.
  
  MarketWatch - 11m

• Spotify swings to a profit as subscribers top estimates

  The streaming service reported a double-digit rise in monthly active users.
  
  MarketWatch - 11m

• Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

  The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.
  
  CNBC - 13m

• The tariff wars aren’t over. China hits back over new 10% tariffs.

  U.S. agreements with Canada and Mexico stopped tariffs before they were to enter into effect, but the trade war between the world’s top two economies is continuing.
  
  MarketWatch - 14m